Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials

SA Goutman, MG Savelieff, SA Sakowski… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of cortical,
brainstem, and spinal motor neurons; it causes progressive muscle weakness and atrophy …

Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials.

SA Goutman, MG Savelieff, SA Sakowski… - Expert Opinion on …, 2019 - europepmc.org
Introduction: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of cortical,
brainstem, and spinal motor neurons; it causes progressive muscle weakness and atrophy …

[HTML][HTML] Stem cell treatments for amyotrophic lateral sclerosis (ALS): A critical overview of early phase trials

SA Goutman, MG Savelieff, SA Sakowski… - Expert opinion on …, 2019 - ncbi.nlm.nih.gov
Introduction: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of cortical,
brainstem, and spinal motor neurons; it causes progressive muscle weakness and atrophy …

[引用][C] Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials

SA Goutman, MG Savelieff, SA Sakowski… - Expert Opinion on …, 2019 - cir.nii.ac.jp
Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials

SA Goutman, MG Savelieff… - Expert opinion on …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of cortical,
brainstem, and spinal motor neurons; it causes progressive muscle weakness and atrophy …